KYIV, Oct 15 (Reuters) - Ukraine is introducing emergency power cuts in all but two regions following a spate of Russian strikes that have hobbled the country's energy system, officials said on ...

PAR Technology Corporation has been a stock in the portfolio since the Fund’s inception. PAR reported a Q2 2025 earnings result that disappointed investors, sending the stock down by 19% in the ...

"It was so unexpected, especially for someone with such strength and spirit," a source tells PEOPLE of the Oscar winner's sudden downturn Michelle Tauber is an Executive Editorial Director at PEOPLE, ...

President Donald Trump suggested he will work to have 2026 FIFA World Cup games pulled out of Boston if the city's mayor, Michelle Wu, does not curb crime that recently included a violent street ...

Once again in Week 6, the Cleveland Browns were unable to come away with a win. They dropped to 1-5 on the year due to their 23-9 loss against Aaron Rodgers and the Pittsburgh Steelers. As the season ...

NFL analyst Tony Rizzo isn’t a fan of Cleveland Browns star pass rusher Myles Garrett after his recent comments. The Browns suffered a 23-9 loss to the Pittsburgh Steelers on the road in Week 6.

As the federal government began a partial shutdown Wednesday, Oct. 1, recent polling continued to show President Donald Trump with low approval ratings eight months into his second term in office.

AppLovin (APP) is back in the spotlight, and you might be wondering why the stock has been catching attention lately. The real story may not be a headline-grabbing event or a dramatic news release, ...

Nina Dobrev is giving fans a glimpse into her recent vacation. In an Instagram post, the 36-year-old "Vampire Diaries" star posted photos from her trip to Paris for fashion week, featuring pictures of ...

SAN DIEGO (FOX 5/KUSI) — The rain isn’t done passing through Southern California just yet, but Tuesday’s storm brought some much needed moisture to San Diego County. The National Weather Service ...

Washington — President Trump frequently touts a U.S. economy that's on the rise under his stewardship: he talks about energy and grocery prices that are falling, lower mortgage rates and claims he's ...

Nektar Therapeutics has recently seen its Consensus Analyst Price Target rise from $96.17 to $101.17. This increase comes as bullish analysts respond to strong Phase 2b results for rezpegaldesleukin ...